MedTrace Logo

Genetic Predisposition for Chronic Non-specific Low Back Pain

NCT02955407 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-01-23

No results posted yet for this study

Summary

Patients with inflammatory back pain were shown to differ from healthy controls in genotype of the Angiotensin-converting enzyme (ACE), which regulates vasoconstriction/-dilatation. The aim of this study is to investigate whether genetic reduction of muscle perfusion might be a pathophysiological pathway of how genes influence chronic non-specific low back pain (LBP).

Conditions

  • Low Back Pain

Interventions

OTHER

no intervention

observational case-control study

Sponsors & Collaborators

  • Balgrist University Hospital

    lead OTHER

Principal Investigators

  • Martin Flück, Professor · Balgrist University Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02955407 on ClinicalTrials.gov